Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and…
The Regeneron Science Talent Search Celebrates and Rewards Today's Most Talented Young Minds Driving Innovation and Progress through Scientific Exploration…
The first investigational FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adult patients: anti-AChR+, anti-MuSK+,…
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…
This collaboration merges advanced analytics with EEG technology for next-level emotional insights CAMBRIDGE, England, Jan. 21, 2025 /PRNewswire/ -- Neuro…
The pricing determination for HCPCS code E3200 will take effect on April 1, 2025PORTLAND, Maine, Jan. 16, 2025 /PRNewswire/ -- MedRhythms,…
Strategic hire underscores Emmes Group's growth and commitment to biopharma market ROCKVILLE, Md., Jan. 16, 2025 /PRNewswire/ -- Emmes Group®,…
Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients.These new advancements in…
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™…
PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest partnership with GOVX, an e-commerce…
